Orthofix International | OFIX - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 82.56M 1.99M 2026-06
Dexcom USD 358.7M 9M 2026-06
EDAP TMS EUR 12.92M 4.1M 2026-03
Globus Medical USD 286.82M 10.95M 2026-06
Inogen USD 43.77M 510K 2024-06
Insulet USD 344.8M 27.6M 2026-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
J&J USD 6.42B 381M 2026-06
Medtronic 2.96B 9M 2025-12
Mesa Laboratories USD 27.31M 380K 2024-09
Orthofix International USD 130.35M 11.31M 2025-12
Plus Therapeutics USD 4.26M 779K 2026-03
Smith & Nephew USD 1.45B 29M 2026-06
STAAR Surgical USD 45.14M 6.5M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Veracyte USD 55.71M 4.87M 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06